Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook.

@article{Mikszta2008CutaneousDO,
  title={Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook.},
  author={John A. Mikszta and Philippe E. Laurent},
  journal={Expert review of vaccines},
  year={2008},
  volume={7 9},
  pages={
          1329-39
        }
}
The skin has long been recognized as an attractive target for vaccine administration. A number of clinical studies have tested the epidermal and dermal routes of delivery using a variety of vaccines over the years. In many cases, cutaneous administration has been associated with immunological benefits, such as the induction of greater immune responses compared with those elicited by conventional routes of delivery. Furthermore, there is a growing body of evidence to suggest that such benefits… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 19 CITATIONS

Chapter 1 Transcutaneous immunization : A general introduction

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of concept.

  • Journal of controlled release : official journal of the Controlled Release Society
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND

Intradermal Immunization

  • Current Topics in Microbiology and Immunology
  • 2012

References

Publications referenced by this paper.
SHOWING 1-10 OF 85 REFERENCES

A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer

  • Cancer Immunology, Immunotherapy
  • 2004
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Microneedles permit transdermal delivery of a skin-impermeant medication to humans.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2008

Coated microneedles for transdermal delivery.

  • Journal of controlled release : official journal of the Controlled Release Society
  • 2007